Babak Edraki — Walnut Creek, California

Babak Edraki is a clinical research site located in Walnut Creek, California, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Babak Edraki has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Walnut Creek

Browse all research sites in California · View every site in Walnut Creek

• University of California, Davis
• Diablo Clinical Research Hospital
• University HealthCare Alliance
• Kaiser Foundation Hospital Walnut Creek
• University of California, Davis Alzheimer's Disease Center
• Aspen Surgery Center/John Muir Hospital
• John Muir Health Hospital, Walnut Creet Medical Center
• University of California, Davis - Health Systems
• Diablo Clinical Research
• Kaiser Permanente-Walnut Creek
• John Muir Medical Center-Walnut Creek
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Babak Edraki?

Babak Edraki has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Babak Edraki conducted?

Babak Edraki has 1 clinical trials on record, with 1 currently active. Their work covers Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV.

Is Babak Edraki accredited by Crixeo Clinical Trials?

Babak Edraki has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Babak Edraki?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.